Form 8-K - Current report:
SEC Accession No. 0001437749-22-008850
Filing Date
2022-04-13
Accepted
2022-04-13 16:00:24
Documents
15
Period of Report
2022-04-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20220413_8k.htm   iXBRL 8-K 27859
2 EXHIBIT 99.1 ex_358145.htm EX-99.1 13761
7 image01.jpg GRAPHIC 7140
  Complete submission text file 0001437749-22-008850.txt   188697

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dyai-20220413.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20220413_def.xml EX-101.DEF 11532
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20220413_lab.xml EX-101.LAB 15414
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20220413_pre.xml EX-101.PRE 11688
9 EXTRACTED XBRL INSTANCE DOCUMENT dyai20220413_8k_htm.xml XML 2575
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 22824697
SIC: 2836 Biological Products, (No Diagnostic Substances)